Prosonix

About:

Prosonix is a speciality pharmaceutical company developing a portfolio of inhaled respiratory medicines.

Top Investors: Ventech, Gilde Healthcare, Gimv, Entrepreneurs Fund, Solon Ventures

Description:

Prosonix is world leader in the commercialization of proprietary pharmaceutical ultrasonic particle engineering technologies and added value ultrasonic process chemistry solutions. A core expertise is the development of new âmolecule to particle' methods for manufacture of inhaled medicines.

Total Funding Amount:

28.5M GBP

Headquarters Location:

Oxford, Oxfordshire, United Kingdom

Founded Date:

2006-01-01

Founders:

David Hipkiss

Number of Employees:

11-50

Last Funding Date:

2012-05-24

IPO Status:

Private

Industries: